Detection and characterization of focal liver lesions using superparamagnetic iron oxide-enhanced magnetic resonance imaging: Comparison between ferumoxides-enhanced T1-weighted imaging and delayed-phase gadolinium-enhanced T1-weighted imaging

Abdominal Imaging

Volumn 28, Issue 4, 2003, Pages 525-530

  Takahama, K ^a   Amano, Y ^a   Hayashi, H ^a   Ishihara, M ^a   Kumazaki, T ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

Cyst; Liver; Magnetic resonance imaging; Metastasis; Superparamagnetic iron oxide

Indexed keywords

GADOBENIC ACID; GADODIAMIDE; GADOLINIUM; GADOLINIUM PENTETATE MEGLUMINE; GADOTERIDOL; GADOVERSETAMIDE; GADOXETIC ACID; MANGAFODIPIR; SUPERPARAMAGNETIC IRON OXIDE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; DIAGNOSTIC IMAGING; FEMALE; HEMANGIOMA; HUMAN; LIVER CELL CARCINOMA; LIVER CYST; LIVER DISEASE; LIVER METASTASIS; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SIDE EFFECT;

CARCINOMA, HEPATOCELLULAR; CONTRAST MEDIA; CYSTS; FEMALE; GADOLINIUM DTPA; HEMANGIOMA; HUMANS; IRON; LIVER; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; OXIDES; SUSPENSIONS;

EID: 0038005146     PISSN: 09428925     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00261-002-0064-9     Document Type: Article

References (19)

1. Ferrucci JT, Stark DD. Iron oxide enhanced imaging of the liver and spleen, review of first 5 years. AJR 1990;155:943-950
2. Low RN. MR imaging of the liver using gadolinium chelates. MR imaging of the liver I: techniques and contrast agents. Magn Reson Imaging Clin North Am 2001;9:717-741
3. Weissleder R. Liver MR imaging with iron oxides: towards consensus and clinical practice. Radiology 1994;193:593-595
4. Reimer P, Rummeny EJ, Daldrup HE, et al. Clinical results with Resovist: a phase 2 clinical trial. Radiology 1995;195:489-496
5. Kreft BP, Tanimoto A, Stark DD, et al. Enhancement of tumor-liver contrast-to-noise ratio with gadobenate dimeglumine in MR imaging of rats. J Magn Reson Imaging 1993;3:41-49
6. Hamm B, Staks T, Muhler A, et al. Phase I clinical evaluation of Gd-EOB-DTPA as a hepatobiliary MR contrast agent: safety, pharmacokinetics, and MR imaging. Radiology 1995;195:785-792
7. Vogl TJ, Hamm B, Schnell B, et al. Mn-DPDP enhancement patterns of hepatocellular lesions on MR images. J Magn Reson Imaging 1993;3:51-58
8. Fretz CJ, Stark DD, Engelstad BL, et al. Detection of hepatic metastases: Comparison of contrast-enhanced CT, unenhanced MR imaging, and iron oxide-enhanced MR imaging. AJR 1990;155:763-770
9. Bellin MR, Zaim S, Auberton E, et al. Liver metastases: safety and efficacy of detection with superparamagnetic iron oxide MR imaging. Radiology 1994;193:657-663
10. Vogl TJ, Hammerstingl R, Schwarz W, et al. Superparamagnetic iron oxide-enhanced versus gadolinium-enhanced MR imaging for differential diagnosis of focal liver lesions. Radiology 1996;198:881-887
11. Grandin C, Van Beers BE, Robert A, et al. Benign hepatocellular tumors: MRI after superparamagnetic iron oxide administration. J Comput Assist Tomogr 1995;9:412-418
12. Nakayama N, Yamashita Y, Mitsuzaki K, et al. Improved tissue characterization of focal liver lesions with ferumoxide-enhanced T1- and T2-weighted MR imaging. J Magn Reson Imaging 2000;11:647-654
13. Poeckier-Schoeniger C, Koepke J, Gueckel F, et al. MRI with superparamagnetic iron oxide: Efficacy in the detection and characterization of focal hepatic lesions. Magn Reson Imaging 1999;17:383-392
14. Sahani D, Saini S, Sharma R, et al. Dynamic T1-weighted SPIO enhanced MRI for imaging liver hemangiomas: preliminary observations. Abdom Imaging 2001;26:166-170
15. Grangier C, Tourniaire J, Mentha G, et al. Enhancement of liver hemangiomas on T1-weighted MR SE images by superparamagnetic iron oxide particles. J Comput Assist Tomogr
16. Pauleit D, Textor J, Bachmann R, et al. Hepatocellular carcinoma: Detection with gadolinium- and SPIO-enhanced MR imaging of the liver. Radiology 2002;222:73-80
17. Tang Y, Yamashita Y, Arakawa A, et al. Detection of hepatocellular carcinoma arising in cirrhotic livers: comparison of gadolinium- and SPIO-enhanced MR imaging. AJR 1999;172:1547-1554
18. Ward J, Guthrie JA, Scott DJ, et al. Hepatocellular carcinoma in the cirrhotic liver: double-contrast MR imaging for diagnosis. Radiology 2000;216:154-162
19. Semelka RC, Lee JKT, Worawattanakul S, et al. Sequential use of ferumoxide particles and gadolinium chelate for the evaluation of focal liver lesions on MRI. J Magn Reson Imaging 1998;8:670-674